2nd Quarter - Report

GOLDBUG STRATEGIES LLC for 23ANDME, INC.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 15, 2016 $30,000 Replaced
2nd Quarter - Report (this page) Jul 15, 2016 $30,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative

LobbyistCovered position, as disclosed
SHEILA D WALCOFF 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative

LobbyistCovered position, as disclosed
SHEILA D WALCOFF 2006-07 Counselor to HHS Secretary Michael O. Leavitt (Immed

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.